112 related articles for article (PubMed ID: 7978833)
1. Effects of matrix metalloproteinases on cartilage biophysical properties in vitro and in vivo.
Bonassar LJ; Paguio CG; Frank EH; Jeffries KA; Moore VL; Lark MW; Caldwell CG; Hagmann WK; Grodzinsky AJ
Ann N Y Acad Sci; 1994 Sep; 732():439-43. PubMed ID: 7978833
[No Abstract] [Full Text] [Related]
2. Activation and inhibition of endogenous matrix metalloproteinases in articular cartilage: effects on composition and biophysical properties.
Bonassar LJ; Stinn JL; Paguio CG; Frank EH; Moore VL; Lark MW; Sandy JD; Hollander AP; Poole AR; Grodzinsky AJ
Arch Biochem Biophys; 1996 Sep; 333(2):359-67. PubMed ID: 8809074
[TBL] [Abstract][Full Text] [Related]
3. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP).
Shapiro SD; Fliszar CJ; Broekelmann TJ; Mecham RP; Senior RM; Welgus HG
J Biol Chem; 1995 Mar; 270(11):6351-6. PubMed ID: 7890773
[TBL] [Abstract][Full Text] [Related]
4. Role of TIMP and MMP inhibition in preventing connective tissue breakdown.
Cawston T; Plumpton T; Curry V; Ellis A; Powell L
Ann N Y Acad Sci; 1994 Sep; 732():75-83. PubMed ID: 7978853
[No Abstract] [Full Text] [Related]
5. Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes.
Murphy G; Cockett MI; Stephens PE; Smith BJ; Docherty AJ
Biochem J; 1987 Nov; 248(1):265-8. PubMed ID: 2829822
[TBL] [Abstract][Full Text] [Related]
6. Production, purification and characterization of canine prostromelysin.
Bayne EK; Hutchinson NI; Walakovits LA; Donatelli S; MacNaul KL; Harper CF; Cameron P; Moore VL; Lark MW
Matrix; 1992 Jun; 12(3):173-84. PubMed ID: 1406451
[TBL] [Abstract][Full Text] [Related]
7. The enzymatic evaluation of procollagenase and collagenase inhibitors in crude biological media.
Lefebvre V; Vaes G
Biochim Biophys Acta; 1989 Sep; 992(3):355-61. PubMed ID: 2550082
[TBL] [Abstract][Full Text] [Related]
8. Stimulation and inhibition of matrix metalloproteinase activities in articular cartilage.
Glazer PA; Azzo W; Saed-Nejad F; Ratcliffe A
Biochem Soc Trans; 1990 Oct; 18(5):1022-3. PubMed ID: 1964646
[No Abstract] [Full Text] [Related]
9. Studies on purified neutral proteoglycan-degrading enzyme (stromelysin/matrix metalloproteinase 3) from human articular cartilage.
Gunja-Smith Z; Nagase H; Woessner JF
Matrix Suppl; 1992; 1():82-3. PubMed ID: 1480097
[No Abstract] [Full Text] [Related]
10. The action of human articular-cartilage metalloproteinase on proteoglycan and link protein. Similarities between products of degradation in situ and in vitro.
Campbell IK; Roughley PJ; Mort JS
Biochem J; 1986 Jul; 237(1):117-22. PubMed ID: 3541894
[TBL] [Abstract][Full Text] [Related]
11. A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro.
Andrews HJ; Plumpton TA; Harper GP; Cawston TE
Agents Actions; 1992 Sep; 37(1-2):147-54. PubMed ID: 1456176
[TBL] [Abstract][Full Text] [Related]
12. Methods for studying activation of matrix metalloproteinases.
Knäuper V; Murphy G
Methods Mol Biol; 2001; 151():377-87. PubMed ID: 11217313
[No Abstract] [Full Text] [Related]
13. Assay of matrix metalloproteinases against matrix substrates.
Cawston TE; Koshy P; Rowan AD
Methods Mol Biol; 2001; 151():389-97. PubMed ID: 11217314
[No Abstract] [Full Text] [Related]
14. Cartilage degradation and associated changes in biochemical and electromechanical properties.
Bonassar LJ; Jeffries KA; Paguio CG; Grodzinsky AJ
Acta Orthop Scand Suppl; 1995 Oct; 266():38-44. PubMed ID: 8553859
[No Abstract] [Full Text] [Related]
15. Matrix metalloproteinase inhibitor CGS 27023A protects COMP and proteoglycan in the bovine articular cartilage but not the release of their fragments from cartilage after prolonged stimulation in vitro with IL-1 alpha.
Ganu V; Melton R; Wang W; Roberts D
Ann N Y Acad Sci; 1999 Jun; 878():607-11. PubMed ID: 10415786
[No Abstract] [Full Text] [Related]
16. Monoclonal antibodies to human MMP-9.
Ramos-DeSimone N; French DL
Ann N Y Acad Sci; 1994 Sep; 732():469-71. PubMed ID: 7978841
[No Abstract] [Full Text] [Related]
17. Chick bone collagenase inhibitor and latency of collagenase.
Sakamoto S; Sakamoto M; Matsumoto A; Nagayama M; Glimcher MJ
Biochem Biophys Res Commun; 1981 Nov; 103(1):339-46. PubMed ID: 6274345
[No Abstract] [Full Text] [Related]
18. Gelatinases and endogenous inhibitors in the preovulatory rat ovary.
Butler TA; Woessner JF
Ann N Y Acad Sci; 1994 Sep; 732():444-6. PubMed ID: 7978834
[No Abstract] [Full Text] [Related]
19. Keratoconus corneas: increased gelatinolytic activity appears after modification of inhibitors.
Brown D; Chwa MM; Opbroek A; Kenney MC
Curr Eye Res; 1993 Jun; 12(6):571-81. PubMed ID: 8359032
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin fragments induce the expression of stromelysin-1 mRNA and protein in bovine chondrocytes in monolayer culture.
Bewsey KE; Wen C; Purple C; Homandberg GA
Biochim Biophys Acta; 1996 Oct; 1317(1):55-64. PubMed ID: 8876627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
